CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.
暂无分享,去创建一个
T. Barbui | S. Bernasconi | V. Facchinetti | M. Introna | A. Rambaldi | G. Borleri | J. Golay | M. Lazzari | S. Bernasconi | A. Rambaldi